Type Whole antibody Target integrin alpha-V CAS Number 725735-28-4 | Source Human ATC code none ChemSpider none | |
Intetumumab is a human monoclonal antibody that was being studied for the treatment of solid tumors.
Intetumumab was developed by Centocor, Inc.
Phase II clinical trials for treatment of melanoma and prostate cancer were in progress when development of the drug was discontinued.
References
Intetumumab Wikipedia(Text) CC BY-SA